AstraZeneca PLC ADRhedged (AMEX: AZNH) Stock Competitors & Peer Comparison
See AZNH's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AZNH and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AZNH | $53.74 | +0.03% | 1.6M | 38.35 | $1.40 | +1.07% |
| RPRX | $66.52 | -0.98% | 29.6B | 12.67 | $5.25 | +1.38% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $80.46 | -0.81% | 8.7B | 229.89 | $0.35 | N/A |
| KNSA | $90.80 | -1.56% | 7.1B | 69.77 | $1.30 | N/A |
| LQDA | $41.85 | -7.12% | 3.7B | 30.55 | $1.37 | N/A |
| PBH | $49.73 | +1.37% | 2.4B | 11.26 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $13.51 | -3.15% | 811.5M | -5.35 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
AZNH vs RPRX Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while RPRX trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas RPRX's P/E ratio is 12.67. In terms of profitability, AZNH's ROE is +0.00%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, AZNH is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
AZNH vs WBA Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas WBA's P/E ratio is -1.64. In terms of profitability, AZNH's ROE is +0.00%, compared to WBA's ROE of -0.57%. Regarding short-term risk, AZNH is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check WBA's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
AZNH vs CORT Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CORT trades at $80.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CORT's P/E ratio is 229.89. In terms of profitability, AZNH's ROE is +0.00%, compared to CORT's ROE of +0.08%. Regarding short-term risk, AZNH is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CORT's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
AZNH vs KNSA Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while KNSA trades at $90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas KNSA's P/E ratio is 69.77. In terms of profitability, AZNH's ROE is +0.00%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, AZNH is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
AZNH vs LQDA Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while LQDA trades at $41.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas LQDA's P/E ratio is 30.55. In terms of profitability, AZNH's ROE is +0.00%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, AZNH is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
AZNH vs PBH Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while PBH trades at $49.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas PBH's P/E ratio is 11.26. In terms of profitability, AZNH's ROE is +0.00%, compared to PBH's ROE of +0.09%. Regarding short-term risk, AZNH is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
AZNH vs HROWL Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas HROWL's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, AZNH is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
AZNH vs HROWM Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas HROWM's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, AZNH is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
AZNH vs LTGO Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while LTGO trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas LTGO's P/E ratio is -5.35. In terms of profitability, AZNH's ROE is +0.00%, compared to LTGO's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
AZNH vs HELP Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HELP trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas HELP's P/E ratio is -2.11. In terms of profitability, AZNH's ROE is +0.00%, compared to HELP's ROE of -0.71%. Regarding short-term risk, AZNH is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
AZNH vs SVA Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas SVA's P/E ratio is -5.68. In terms of profitability, AZNH's ROE is +0.00%, compared to SVA's ROE of -0.01%. Regarding short-term risk, AZNH is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
AZNH vs CUVL Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CUVL trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CUVL's P/E ratio is 10.68. In terms of profitability, AZNH's ROE is +0.00%, compared to CUVL's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
AZNH vs HITI Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HITI trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas HITI's P/E ratio is -9.57. In terms of profitability, AZNH's ROE is +0.00%, compared to HITI's ROE of -0.36%. Regarding short-term risk, AZNH is less volatile compared to HITI. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
AZNH vs CELG-RI Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CELG-RI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, AZNH is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
AZNH vs ETRA Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ETRA trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas ETRA's P/E ratio is -2.76. In terms of profitability, AZNH's ROE is +0.00%, compared to ETRA's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
AZNH vs TRXB Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, TRXB has a market cap of 114.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while TRXB trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas TRXB's P/E ratio is -5.56. In terms of profitability, AZNH's ROE is +0.00%, compared to TRXB's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to TRXB. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check TRXB's competition here
Atlantic International Corp. (NASDAQ: ATLN)
AZNH vs ATLN Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas ATLN's P/E ratio is -0.68. In terms of profitability, AZNH's ROE is +0.00%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, AZNH is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
AZNH vs CTOR Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CTOR trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CTOR's P/E ratio is -1.26. In terms of profitability, AZNH's ROE is +0.00%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, AZNH is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
AZNH vs RTSN Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while RTSN trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas RTSN's P/E ratio is -4.45. In terms of profitability, AZNH's ROE is +0.00%, compared to RTSN's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
AZNH vs RAD Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas RAD's P/E ratio is -0.05. In terms of profitability, AZNH's ROE is +0.00%, compared to RAD's ROE of +2.76%. Regarding short-term risk, AZNH is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
AZNH vs GLTO Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas GLTO's P/E ratio is -1.78. In terms of profitability, AZNH's ROE is +0.00%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, AZNH is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check GLTO's competition here
Cosmos Health Inc. (NASDAQ: COSM)
AZNH vs COSM Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while COSM trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas COSM's P/E ratio is -0.42. In terms of profitability, AZNH's ROE is +0.00%, compared to COSM's ROE of -1.19%. Regarding short-term risk, AZNH is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check COSM's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
AZNH vs NSRX Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while NSRX trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas NSRX's P/E ratio is -4.44. In terms of profitability, AZNH's ROE is +0.00%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, AZNH is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
AZNH vs SCYX Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SCYX trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas SCYX's P/E ratio is -1.11. In terms of profitability, AZNH's ROE is +0.00%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, AZNH is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check SCYX's competition here
Pomdoctor Limited (NASDAQ: POM)
AZNH vs POM Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while POM trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas POM's P/E ratio is -0.28. In terms of profitability, AZNH's ROE is +0.00%, compared to POM's ROE of +0.80%. Regarding short-term risk, AZNH is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check POM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
AZNH vs BFRI Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BFRI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas BFRI's P/E ratio is -1.59. In terms of profitability, AZNH's ROE is +0.00%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, AZNH is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
AZNH vs CNSY Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CNSY trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CNSY's P/E ratio is -0.41. In terms of profitability, AZNH's ROE is +0.00%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, AZNH is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CNSY's competition here
Azora Therapeutics, Inc. (NASDAQ: AZR)
AZNH vs AZR Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while AZR trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas AZR's P/E ratio is -0.24. In terms of profitability, AZNH's ROE is +0.00%, compared to AZR's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to AZR. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check AZR's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
AZNH vs CJJD Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CJJD's P/E ratio is -0.46. In terms of profitability, AZNH's ROE is +0.00%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, AZNH is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
AZNH vs SSY Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas SSY's P/E ratio is -2.86. In terms of profitability, AZNH's ROE is +0.00%, compared to SSY's ROE of -0.09%. Regarding short-term risk, AZNH is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
AZNH vs SCNX Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SCNX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas SCNX's P/E ratio is -1.54. In terms of profitability, AZNH's ROE is +0.00%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, AZNH is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
AZNH vs BGMS Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas BGMS's P/E ratio is -0.25. In terms of profitability, AZNH's ROE is +0.00%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, AZNH is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check BGMS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
AZNH vs MDVL Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas MDVL's P/E ratio is -0.05. In terms of profitability, AZNH's ROE is +0.00%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, AZNH is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check MDVL's competition here
Eocene Ltd. (NASDAQ: EOCN)
AZNH vs EOCN Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while EOCN trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas EOCN's P/E ratio is -0.19. In terms of profitability, AZNH's ROE is +0.00%, compared to EOCN's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check EOCN's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
AZNH vs PAVS Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while PAVS trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas PAVS's P/E ratio is -0.03. In terms of profitability, AZNH's ROE is +0.00%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, AZNH is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
AZNH vs ATNFW Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas ATNFW's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, AZNH is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
AZNH vs BGMSP Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, AZNH's ROE is +0.00%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, AZNH is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check BGMSP's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP)
AZNH vs ASBP Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ASBP trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas ASBP's P/E ratio is -0.31. In terms of profitability, AZNH's ROE is +0.00%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, AZNH is less volatile compared to ASBP. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ASBP's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
AZNH vs BFRIW Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BFRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas BFRIW's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, AZNH is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check BFRIW's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
AZNH vs LFLYW Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, AZNH's ROE is +0.00%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, AZNH is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check LFLYW's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW)
AZNH vs ASBPW Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ASBPW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas ASBPW's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, AZNH is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ASBPW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
AZNH vs PRPH Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas PRPH's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, AZNH is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check PRPH's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
AZNH vs OREX Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, OREX has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas OREX's P/E ratio is -0.14. In terms of profitability, AZNH's ROE is +0.00%, compared to OREX's ROE of -0.54%. Regarding short-term risk, AZNH is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check OREX's competition here
Shire plc (NASDAQ: SHPG)
AZNH vs SHPG Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas SHPG's P/E ratio is 11.35. In terms of profitability, AZNH's ROE is +0.00%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, AZNH is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check SHPG's competition here
POZEN Inc. (NASDAQ: POZN)
AZNH vs POZN Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, POZN has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas POZN's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to POZN's ROE of +0.61%. Regarding short-term risk, AZNH is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check POZN's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
AZNH vs ESRX Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas ESRX's P/E ratio is 10.69. In terms of profitability, AZNH's ROE is +0.00%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, AZNH is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check ESRX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
AZNH vs IPXL Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas IPXL's P/E ratio is -10.11. In terms of profitability, AZNH's ROE is +0.00%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, AZNH is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check IPXL's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
AZNH vs CPD Comparison November 2026
AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZNH stands at 1.6M. In comparison, CPD has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZNH currently has a P/E ratio of 38.35, whereas CPD's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to CPD's ROE of N/A. Regarding short-term risk, AZNH is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check CPD's competition here